ERLONAT 150MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹2804.37

NATCO PHARMA LTD (ONCOLOGY DIV): Erlonat 150MG Tablet, 30 tablets, salt erlotinib 150mg. NPPA has revised its MRP from Rs 8,768.66 to Rs 2,804.37 (68% lower) with effect from 09-11-2026; trade rate Rs 2,136.66. Group: EGFR tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Hetero, Neon, Reliance Life Sciences. Handling/counselling: take on an empty stomach; smoking reduces its effect. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.